We are live on ! Find out more
LCM

Laurion Capital Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 75.73%
This Fund
S&P 500
This Quarter Est. Return
-18.86%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$5.66B
AUM Growth
-$4.65B
Cap. Flow
-$3.49B
Cap. Flow %
-61.69%
Top 10 Hldgs %
17.92%
Holding
1,607
New
464
Increased
260
Reduced
291
Closed
542

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$177M
2
PTC icon
PTC
PTC
+$53.5M
3
UNP icon
Union Pacific
UNP
+$47.5M
4
NCLH icon
Norwegian Cruise Line
NCLH
+$44.4M
5
GOOS
Canada Goose Holdings
GOOS
+$43.6M

Top Sells

Rank Stock Value
1
AABA
Altaba Inc
AABA
+$203M
2
DELL icon
Dell
DELL
+$83.5M
3
GDDY icon
GoDaddy
GDDY
+$78.6M
4
MEDP icon
Medpace
MEDP
+$57.2M
5
PRAH
PRA Health Sciences, Inc.
PRAH
+$48.1M

Sector Composition

Rank Sector Weight
1 Technology 8.72%
2 Healthcare 6.44%
3 Industrials 4.47%
4 Consumer Discretionary 4.29%
5 Financials 2.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AYI icon
1101
Acuity Brands
AYI
$10.8B
-1,385
Closed -$218K
AZN icon
1102
AstraZeneca
AZN
$250B
-2,850
Closed -$226K
AZZ icon
1103
AZZ Inc
AZZ
$4.54B
-4,300
Closed -$217K
BALL icon
1104
Ball Corp
BALL
$16.8B
-14,185
Closed -$624K
BC icon
1105
Brunswick
BC
$5.28B
-7,553
Closed -$506K
BE icon
1106
Bloom Energy
BE
$64.6B
-400,000
Closed -$13.6M
BEN icon
1107
Franklin Resources
BEN
$17.2B
-8,057
Closed -$245K
BFAM icon
1108
Bright Horizons
BFAM
$3.86B
-59,359
Closed -$7M
BFS
1109
Saul Centers
BFS
$841M
-5,742
Closed -$322K
BGFV
1110
DELISTED
Big 5 Sporting Goods
BGFV
-12,800
Closed -$65K
BHC icon
1111
CALL
Bausch Health
BHC
$2.34B
-115,300
Closed -$2.96M
BBT
1112
Beacon Financial Corp
BBT
$2.66B
-5,024
Closed -$204K
BJ icon
1113
BJs Wholesale Club
BJ
$12.3B
-100,000
Closed -$2.68M
BLD
1114
DELISTED
TopBuild
BLD
-5,766
Closed -$328K
BLKB icon
1115
Blackbaud
BLKB
$2.08B
-5,310
Closed -$539K
BLMN icon
1116
Bloomin' Brands
BLMN
$938M
-70,476
Closed -$1.4M
BMRN icon
1117
CALL
BioMarin Pharmaceuticals
BMRN
$12.4B
-4,200
Closed -$407K
BMRN icon
1118
BioMarin Pharmaceuticals
BMRN
$12.4B
-266
Closed -$26K
BMRN icon
1119
PUT
BioMarin Pharmaceuticals
BMRN
$12.4B
-500
Closed -$48K
BMY icon
1120
CALL
Bristol-Myers Squibb
BMY
$132B
-750,100
Closed -$46.6M
BOOT icon
1121
Boot Barn
BOOT
$4.95B
-39,474
Closed -$1.12M
BRK.B icon
1122
Berkshire Hathaway Class B
BRK.B
$1.13T
-2,971
Closed -$636K
BSX icon
1123
CALL
Boston Scientific
BSX
$71.5B
-28,900
Closed -$1.11M
BTA
1124
DELISTED
BlackRock Long-Term Municipal Advantage Trust
BTA
-10,634
Closed -$120K
BTI icon
1125
British American Tobacco
BTI
$128B
-6,400
Closed -$298K

Similar funds

Laurion Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Laurion Capital Management held 1,607 positions worth $5.66B, down 45% from $10.3B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Laurion Capital Management withdrew a net $3.49B in Q4 2018, closing 542 positions and reducing 291 holdings. Its most notable exit was Altaba Inc, an estimated $203M position sold in full.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 7% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Laurion Capital Management opened a new position in Union Pacific worth $44.3M.

  • Laurion Capital Management's largest Q4 2018 buy was Union Pacific: 320,420 shares worth $44.3M.
  • Laurion Capital Management added most to Qualcomm in Q4 2018, an estimated $177M increase.
  • Laurion Capital Management's biggest Q4 2018 reduction was Dell, cutting an estimated $83.5M.
  • Laurion Capital Management fully exited Altaba Inc in Q4 2018, selling an estimated $203M.
  • Laurion Capital Management's ten largest holdings make up 18% of its $5.66B portfolio in Q4 2018.
  • Laurion Capital Management opened 464 new positions and closed 542 in Q4 2018.
  • Laurion Capital Management's portfolio value fell 45% quarter-over-quarter to $5.66B.

Based on Laurion Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.